Dantrolene Ameliorates Impaired Neurogenesis and Synaptogenesis in Induced Pluripotent Stem Cell Lines Derived from Patients with Alzheimer's Disease

被引:22
|
作者
Wang, Yong [1 ,2 ]
Liang, Ge [1 ]
Liang, Shuqing [1 ,3 ]
Mund, Rachel [4 ]
Shi, Yun [1 ,5 ]
Wei, Huafeng [1 ]
机构
[1] Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA
[2] Guangzhou Univ Chinese Med, Affiliated Hosp 1, Dept Anesthesiol, Guangzhou, Peoples R China
[3] Jinan Univ, Affiliated Hosp 1, Dept Anesthesiol, Guangzhou, Peoples R China
[4] Univ Penn, Coll Art & Sci, Philadelphia, PA 19104 USA
[5] Fudan Univ, Childrens Hosp, Dept Anesthesiol, Shanghai, Peoples R China
基金
美国国家卫生研究院;
关键词
AUTOPHAGY; MEMORY; DISRUPTION; MECHANISM; NEURONS; MODELS; ADULT; DEATH; YOUNG;
D O I
10.1097/ALN.0000000000003224
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: Overactivation of ryanodine receptors and the resulting impaired calcium homeostasis contribute to Alzheimer's disease-related pathophysiology. This study hypothesized that exposing neuronal progenitors derived from induced pluripotent stems cells of patients with Alzheimer's disease to dantrolene will increase survival, proliferation, neurogenesis, and synaptogenesis. Methods: Induced pluripotent stem cells obtained from skin fibroblast of healthy subjects and patients with familial and sporadic Alzheimer's disease were used. Biochemical and immunohistochemical methods were applied to determine the effects of dantrolene on the viability, proliferation, differentiation, and calcium dynamics of these cells. Results: Dantrolene promoted cell viability and proliferation in these two cell lines. Compared with the control, differentiation into basal forebrain cholinergic neurons significantly decreased by 10.7% (32.9 +/- 3.6% vs. 22.2 +/- 2.6%, N = 5, P = 0.004) and 9.2% (32.9 +/- 3.6% vs. 23.7 +/- 3.1%, N = 5, P = 0.017) in cell lines from sporadic and familial Alzheimer's patients, respectively, which were abolished by dantrolene. Synapse density was significantly decreased in cortical neurons generated from stem cells of sporadic Alzheimer's disease by 58.2% (237.0 +/- 28.4 vs. 99.0 +/- 16.6 arbitrary units, N = 4, P = 0.001) or familial Alzheimer's disease by 52.3% (237.0 +/- 28.4 vs.113.0 +/- 34.9 vs. arbitrary units, N = 5, P = 0.001), which was inhibited by dantrolene in the familial cell line. Compared with the control, adenosine triphosphate (30 mu M) significantly increased higher peak elevation of cytosolic calcium concentrations in the cell line from sporadic Alzheimer's patients (84.1 +/- 27.0% vs. 140.4 +/- 40.2%, N = 5, P = 0.049), which was abolished by the pretreatment of dantrolene. Dantrolene inhibited the decrease of lysosomal vacuolar-type H+-ATPase and the impairment of autophagy activity in these two cell lines from Alzheimer's disease patients. Conclusions: Dantrolene ameliorated the impairment of neurogenesis and synaptogenesis, in association with restoring intracellular Ca2+ homeostasis and physiologic autophagy, cell survival, and proliferation in induced pluripotent stem cells and their derived neurons from sporadic and familial Alzheimer's disease patients.
引用
收藏
页码:1062 / 1079
页数:18
相关论文
共 50 条
  • [1] Human-Induced Pluripotent Stem Cell-Derived Neural Cells from Alzheimer's Disease Patients Exhibited Different Susceptibility to Oxidative Stress
    Lin Zhang
    Mei Xu
    Qiao Ren
    Gang Liu
    Meng, Shulin
    Kang Xiahou
    Zhang, Yongxiang
    Ning Jiang
    Zhou, Wenxia
    STEM CELLS AND DEVELOPMENT, 2020, 29 (22) : 1444 - 1456
  • [2] Induced pluripotent stem cell (iPSC)-derived dopaminergic models of Parkinson's disease
    Beevers, Joel E.
    Caffrey, Tara M.
    Wade-Martins, Richard
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2013, 41 : 1503 - 1508
  • [3] Induced Pluripotent Stem Cell-Derived Astroglia: A New Tool for Research Towards the Treatment of Alzheimer's Disease
    Atkinson-Dell, Rebecca
    Mohamet, Lisa
    NEUROGLIA IN NEURODEGENERATIVE DISEASES, 2019, 1175 : 383 - 405
  • [4] Intranasal administration of induced pluripotent stem cell-derived cortical neural stem cell-secretome as a treatment option for Alzheimer's disease
    Mo, Hyunkyung
    Kim, Juryun
    Kim, Jennifer Yejean
    Kim, Jang Woon
    Han, Heeju
    Choi, Si Hwa
    Rim, Yeri Alice
    Ju, Ji Hyeon
    TRANSLATIONAL NEURODEGENERATION, 2023, 12 (01)
  • [5] Human Dendritic Cell-Derived Induced Pluripotent Stem Cell Lines Are Not Immunogenic
    Chhabra, Arvind
    Chen, I-Ping
    Batra, Deepika
    JOURNAL OF IMMUNOLOGY, 2017, 198 (05) : 1875 - 1886
  • [6] Induced pluripotent stem cells as a discovery tool for Alzheimer's disease
    Sullivan, Sarah E.
    Young-Pearse, Tracy L.
    BRAIN RESEARCH, 2017, 1656 : 98 - 106
  • [7] Mesenchymal stem cell-derived exosomes promote neurogenesis and cognitive function recovery in a mouse model of Alzheimer's disease
    Reza-Zaldivar, Edwin E.
    Hernandez-Sapiens, Mercedes A.
    Gutierrez-Mercado, Yanet K.
    Sandoval-Avila, Sergio
    Gomez-Pinedo, Ulises
    Marquez-Aguirre, Ana L.
    Vazquez-Mendez, Estefania
    Padilla-Camberos, Eduardo
    Canales-Aguirre, Alejandro A.
    NEURAL REGENERATION RESEARCH, 2019, 14 (09) : 1626 - 1634
  • [8] NEUBOrg: Artificially Induced Pluripotent Stem Cell-Derived Brain Organoid to Model and Study Genetics of Alzheimer's Disease Progression
    Esmail, Sally
    Danter, Wayne R.
    FRONTIERS IN AGING NEUROSCIENCE, 2021, 13
  • [9] Probing the Secrets of Alzheimer's Disease Using Human-induced Pluripotent Stem Cell Technology
    Goldstein, Lawrence S. B.
    Reyna, Sol
    Woodruff, Grace
    NEUROTHERAPEUTICS, 2015, 12 (01) : 121 - 125
  • [10] Chronic Memantine Treatment Ameliorates Behavioral Deficits, Neuron Loss, and Impaired Neurogenesis in a Model of Alzheimer's Disease
    Stazi, Martina
    Wirths, Oliver
    MOLECULAR NEUROBIOLOGY, 2021, 58 (01) : 204 - 216